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Abstract: 
Background 
Erythema multiforme (EM) is an acute, vesiculobullous disease of skin and mucous 
membranes with symptoms ranging from mild to severe. A complex interaction of different 
factors has been implicated to cause the condition; majority with a preceding herpes simplex 
infection. This report describes an unusual presentation of erythema multiforme affecting the 
lips and oral mucosa of a healthy 7-year-old boy in the form of lip adherence. 
Case report 
Two weeks following eruption of oral ulcerations, a 7-year-old healthy boy patient developed 
severe erosive ulceration of both lips, causing complete lip adherence. This was accompanied 
by marked bilateral submandibular and cervical lymphadenopathy, tremor and sweating. 
Clinical and laboratory investigations led to a diagnosis of erythema multiforme. The patient 
was treated initially with gentle application of Vaseline between the lips using cotton buds in 
an attempt to release lip adhesion, followed by surgical release of the lips under general 
anaesthesia. Analgesics and topical steroid mouthwash were provided. 
Follow-up 
Seven months later, the patient presented with a flare up of his EM which included target 
lesions on the skin. Patient was treated with antivirals, topical and systematic steroids to 
supress the recurrent attacks of EM. Eighteen months following initial presentation the 
patient and parent reported considerable decrease in the frequency, severity and duration of 
the occurrence of intra-oral ulcers with no major episode of target lesions on the skin.   
Conclusion 
Erythema multiforme is rare in children, however should be considered in the differential 
diagnosis of recurrent erosive oral ulcerative lesions especially when the oral lesions 
resemble those of primary herpetic gingivostomatitis.  
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Background 
Erythema multiforme (EM) is an acute, vesiculobullous disease of skin and mucous 
membranes described first by Hebra in 1866 [Léauté-Labrèze et al., 2000; Ayangco et al., 
2001]. The condition predominately affects young adults with an incidence of approximately 
0.01%–1% per year and a peak age of 20–40 year [Jawetz et al 2007]. However, 20% of the 
cases occur in children with a higher incidence in males compared to females [Atzori et al., 
2003; Field and Longman, 2003; Jawetz et al., 2007; Scully and Bagan, 2008]. EM can be 
precipitated by range of factors; the most of which is with a preceding herpes simplex 
infection. Other important stimulating factors include infections, drugs (such as 
sulphonamides, cephalosporins and anticonvulsants), neoplastic and autoimmune diseases. 
Yet, less than half of EM cases occur without a trigger [Atzori et al., 2003; Field and 
Longman, 2003].  
Depending on the clinical presentation of the condition, EM is classified into EM minor, EM 
major and Stevens–Johnson syndrome. In the minor form, the symptoms are usually mild, 
self-limiting and mainly confined to the oral cavity whereas in EM major, the clinical picture 
is more severe and involves at least two different mucosal sites including the oral mucosa. 
Stevens–Johnson syndrome is a more progressive, fulminating, severe variant of EM that is 
characterised by widespread lesions involving the skin and other mucous membranes such as 
the oral cavity, eyes, pharynx, larynx, oesophagus, and genitals. The condition is potentially 
life-threatening and in some cases is associated with flu-like symptoms, fever, sore throat, 
headache, arthralgias, myalgias, pneumonia, nephritis, or myocarditis condition [Al-Johani et 
al., 2007; Scully and Bagan, 2008]. 
The characteristic appearance of EM includes symmetrically distributed skin lesions located 
predominantly on the exterior skin of the extremities and less frequently on the palms and 
soles, with a tendency to reoccur usually in a time period ranging from few weeks to almost a 
year [Léauté-Labrèze et al., 2000]. The classic skin presentation is that of target or iris-like 
lesions defined as “ individual lesions less than 3 cm diameter with a regular round shape, a 
well-defined border, and two concentric palpable oedematous rings, paler than the centre 
disc ” [Scully and Bagan, 2008].  
Oral mucosa is involved in 70% of the cases, characteristically affecting the lips (especially 
the lower lip). Intraoral lesions typically appear on the non-keratinised mucosa and mostly 
seen in the anterior parts of the mouth. Lips tend to swell, crack, bleed and crust.  
Lachrimation and photophobia can be observed in patients presented with EM involving the 
ocular area, whereas genital lesions (if present) are usually painful and may result in urinary 
retention [Ayangco et al., 2001; Field and Longman, 2003; Scully and Bagan, 2008]. 
The initial diagnosis of EM is entirely clinical as there are no specific diagnostic tests for EM.  
Perilesional tissue biopsy is usually performed to support the diagnosis of EM which usually 
has a non-specific histological appearance with degenerative changes in the epithelium and 
subepithelial bulla formation. Immunofluorescence studies are needed to exclude other 
immunobullous diseases such as pemphigus and pemphigoid [Field and Longman, 2003; 
Scully and Bagan, 2008].  
Depending on the severity of the condition, EM is treated using local and/or systematic 
steroids. Long-term prophylactic acyclovir is required in patients with recurrent episodes of 
EM. In severe forms, hospital admission is required particularly if the patient become 
dehydrated [Field and Longman, 2003].     
The aim of this report is to describe an unusual presentation of erythema multiforme affecting 
the lips and oral mucosa of a healthy 7-year-old boy and resulting in adherence of the lips.  
 
Case report 
History and examination: 
A 7-year-old boy was urgently referred to the paediatric department at the Leeds Dental 
Institute (LDI) by his general dental practitioner for evaluation and treatment of painful oral 
ulceration that resulted in adhesion of the lips preventing the child from opening his mouth.   
On examination (Figure 1), the patient presented with severe erosive ulceration of both lips 
causing lip adherence. The erosive lesions were yellow-grey in colour with erythematous 
borders. The patient reported experiencing oral ulcerations two to three weeks prior to his 
examination. Ulcers affecting the lips appeared five days earlier, and resulted in adherence of 
the lips the day before. The patient was unable to eat or drink for the last 20 hours; however, 
was responsive, oriented in time, place and person and showed no signs of dehydration. 
There were no extra-oral lesions however the patient had marked bilateral submandibular and 
cervical lymphadenopathy. 
 
The patient had a history of recurrent severe oral ulceration affecting the mouth and lips, 
occurring 5-6 times over the past 18 months. There was no pattern of recurrence associated 
with these ulcers. Erosive ulcers appeared mainly on the lips, eyes and nose over a course of 
2-3 weeks at a time. These ulcers were accompanied by tremor and sweating with no 
development of pyrexia. In addition, the patient reported recurrent cold sores which 
previously preceded the oral ulceration on some occasions.  The patient was otherwise 
healthy with no relevant past medical history.  
 
Management: 
Initial management: 
The initial management involved gentle application of Vaseline (petroleum gel) between the 
lips using cotton buds in an attempt to release lip adhesion. This technique helped release 
most of the adherent lesions except for a small (~1cm) area on the right side (Figure 1) 
allowing the patient to eat and drink. After discussing the case with maxillofacial colleagues, 
the patient was allowed to go home that evening with a review appointment with one of the 
maxillofacial surgeons the next morning. The patient was prescribed Difflam mouth rinse, 
(Benzydamine hydrochloride), chlorhexidine 0.2% mouthwash and advised to keep applying 
Vaseline on the lips to prevent recurrent adhesion. 
Further management and investigations: 
Unfortunately, the patient presented the next morning with fused lips despite using Difflam 
and Vaseline. The patient was, therefore, admitted under the maxillofacial department for 
intravenous (I.V) fluids, surgical release of his lips, incisional biopsy and blood tests under 
general anaesthesia.  
The biopsy showed non-specific ulceration with neither intraepithelial sub-basal clefting nor 
dysplastic features. Direct immunofluorescence revealed negative autoantibodies (IgG, IgA, 
IgM, C3c and fibrinogen) and no abnormalities were detected in the haematological 
investigations (negative antinuclear antibodies (ANA) and anti-neutrophil cytoplasmic 
antibody (ANCA) screen).  
A diagnosis of erythema multiforme was, therefore, made and the patient was prescribed 
betamethasone (betnesol) mouthwash 0.5 mg four times a day for two weeks.  
 
Review and follow-up: 
One week later, the symptoms had subsided considerably, however, the patient presented 
with ulcerations associated with pseudomembranous slough on the lower lip, posterior 
surface of the tongue, and the mucosal surface of both right and left sides of the oral 
commissures.  
The lesions completely healed three weeks later and therefore, it was decided to keep the 
patient under observation. Should the lesions recur, the patient was instructed to use a 3-4 
days course of prednisolone with a starting dose of 15 mg. 
Seven months later, the patient had a flare up of his EM that included extra-oral lesions 
(Figure 2 a-f). Ulcers appeared on the lips and eyes accompanied by target lesions on the skin. 
Mild cervical lymphadenopathy and facial swelling were noted as well. The patient was 
prescribed systemic prednisolone and topical steroid mouthwash. In addition, the patient was 
prescribed oral acyclovir as prophylactic measure to supress the recurrent attacks of EM.  
Eighteen months follow up appointment revealed the presence of an intra-oral ulcer on the 
left mucosa of the lower lip which had been present for the last two days (Figure 3 a-h). No 
other intra-oral lesions were identified. Mildly enlarged tonsils were noticed which was not 
associated with any pyrexia or lymphadenopathy. The patient reported experiencing intra-oral 
ulcers approximately every 4 months in the last 12 months with no major episode of target 
skin lesions. Each episode of intra-oral ulceration lasted for about 3 days before healing. 
These lesions mostly affected the lower lip mucosa, cheeks and palate.       
The patient was advised to use prednisolone and chlorhexidine 0.2% mouthwash at flare ups 
of intra-oral ulcers. He was also advised to start systemic steroid in the case of significant 
progression of oral ulcers, recurrence of target lesions on the body and should the patient feel 
unwell.     
    
 
 
  
Discussion 
Erythema multiforme is an acute, self-limiting, mucocutaneous disorder, with many patients 
experiencing more than one attack [Schofield et al., 1993] and where the main cause remains 
unknown. However, it is believed that a complex interaction of different factors has to play a 
role in the initiation of the signs and symptoms of the condition. Recurrent herpes simplex 
virus infection is considered to be the most common cause of recurrent EM [Ayangco et al., 
2001]. 
Although the initial diagnosis of EM is based entirely on the clinical presentation of the 
condition, the diagnosis can be challenging particularly when there are no extra-oral lesions 
[Ayangco et al., 2001]. These patients can present with many variable features which can 
mimic other conditions; therefore, a biopsy of the oral lesions and immunofluorescence 
studies must be carried out to exclude other potential conditions. The differential diagnosis of 
early erythema multiforme includes pemphigus and pemphigoid, ulcerative conditions such 
as primary herpetic gingivostomatitis, drug eruption, Behçets disease, urticaria, and other 
hypersensitivity reactions [Lamoreux et al., 2006]. 
The oral mucosal ulcerations of primary herpetic gingivostomatitis are often similar to those 
of EM [Farthing et al., 1995]. However, ulcerative lesions of primary herpetic 
gingivostomatitis usually affect the gingiva and hard palate, and do not tend to reoccur 
[Farthing et al., 1995].  
Pemphigus and pemphigoid are a group of immunobullous disorders that are characterised by 
widespread formation of bullae on the skin and mucous membranes. Where skin lesions are 
absent, extensive oral ulceration can be confused with EM [Farthing et al., 1995]. In the case 
presented, vesicles or bullae did not precede the lesions; therefore, a diagnosis of pemphigus 
or pemphigoid was unlikely. In addition, ANA and ANCA screens were negative for 
autoantibodies such as IgG and C3 present in patients affected by pemphigus and pemphigoid.  
Urticaria is another differential diagnosis of EM especially at the onset of eruption of the 
lesions [Lamoreux et al., 2006]. In EM, the characteristic skin lesions tend to last at least one 
week whereas urticarial lesions present usually in patients for less than 24 hours. 
The patient presented here suffered recurrent severe oral ulcerations affecting the lips with 
subsequent development of target lesions on the skin. Investigations including biopsy of the 
oral mucosa and direct immunofluorescence were negative for other potential conditions.  
It has been cited in the literature that the involvement of the lips is a strong indication of the 
diagnosis of EM and the presence of target lesion of the skin is almost a pathognomonic 
feature for the diagnosis of EM (Steven’s Johnson Syndrome) [Ayangco et al., 2001; Field 
and Longman, 2003; Scully and Bagan, 2008].  
This case also shows an unusual presentation of erythema multiforme in a child, which 
resulted in complete adherence of the lips requiring surgical intervention. Management of 
erythema multiforme is largely dependent on the severity of the condition [Farthing et al., 
1995; Ayangco et al., 2001; Lamoreux et al., 2006].  
The presence of an inducing factor should be investigated when possible with suspected 
infectious diseases treated in the first instance and causal drugs withdrawn. 
Several reports have shown that recurrent EM attacks can be suppressed effectively by oral 
acyclovir even if herpes simplex virus (HSV) is not an obvious triggering factor [Schofield et 
al., 1993; Ayangco et al., 2001; Habif, 2004]. HSV DNA has been detected using the 
polymerase chain reaction in the cutaneous lesions of EM patients with clinically non-HSV-
associated disease emphasising the primary role of HSV reactivation in the initiation of EM 
signs and symptoms [Brice et al., 1989; Darregh et al., 1991]. However, it should be noted 
that not all episodes of EM are precipitated by HSV infection, and not all HSV infection 
precipitates EM in individual patients.  
This patient reported a history of recurrent cold sores that might precede an EM attack but did 
not always lead to EM. Therefore, it was suggested that the patient`s recurrent episodes of 
EM were mainly secondary to HSV reactivation.  
Symptomatic treatment including systemic or topical analgesics, soothing mouth rinses and 
antibiotic treatment for secondary infection should be provided to patients presenting with 
mild variants of EM. On the other hand, hospitalisation is required for those with more severe 
forms, particularly when the skin or oral lesions are severely affected or when the eyes are 
involved. There is no sufficient evidence in the literature to support the use of systematic 
steroids in mild forms of the disease; however, systemic steroids could be beneficial in the 
severe cases of the condition to prevent further progression of the disease [Ayangco et al., 
2001].  
This case has been managed initially by releasing the lip adherence by gentle application of 
Vaseline using cotton buds on the day of the patient presentation followed by surgical release 
of fused lips under general anaesthesia.  
Benzydamine hydrochloride, chlorhexidine mouthwash and a topical steroid rinse were 
initially prescribed. Whereas the final management involved local and systemic steroids due 
to the recurrent existence of severe ulceration on the lips, mouth and skin. Acyclovir was also 
added to the regimen as a prophylactic measure in order to suppress any likely future EM 
attacks. The patient showed good response to the above treatment regime and is currently 
under regular review.   
Conclusion 
Erythema multiforme is rare in children, however; should be considered in the differential 
diagnosis of recurrent erosive oral ulcerative lesions especially when the oral lesions 
resemble those of primary herpetic gingivostomatitis. Referral to an oral medicine or 
maxillofacial department is crucial for the investigation and management of these cases.  
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Figure 1: Photograph showing ulcerated fused upper and lower lips after releasing the 
adherence using a cotton bud covered with Vaseline. 
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Figure 2: Photographs showing intra- and extra-oral lesions 7 months following initial 
presentation with (a, b) target lesions on the skin of the neck, (c,d) white plaques with a spongy, 
corrugated surface affecting the buccal mucosa on both sides, (e,f) grey-yellow ulceration of the 
lips with erythematous borders involving the vermillion border, left commissure of the mouth 
and the skin peri-orally (e also shows ulceration of the anterior region of the tongue mostly 
affecting the dorsal surface). 
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Figure 3: Photographs at 18 months follow-up appointment showing (a, b) healing of the 
extra- oral skin lesions, (c,d,e) healing of most of the lip lesions and a 2-3 mm intra-oral ulcer 
on the mucosa of lower lip, (f,g,h) healing of intra-oral soft tissue lesions on the lips and 
buccal mucosa.  
  
 
